1. Jani B, Rajkumar C. Ageing and vascular ageing. Postgrad Med J. 2006; 82:357–362.
Article
2. Booth GL, Kapral MK, Fung K, Tu JV. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet. 2006; 368:29–36.
Article
3. Park YJ, Kim N, Kim YW. Investigation of Current Trend of AAA Treatment in Korea. J Korean Surg Soc. 2011; 80:125–130.
Article
4. Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 1999; 100:1481–1492.
Article
5. Jang SY, Ju EY, Cho SI, Lee SW, Kim DK. Comparison of cardiovascular risk factors for peripheral artery disease and coronary artery disease in the Korean population. Korean Circ J. 2013; 43:316–328.
Article
6. Weisell RC. Body mass index as an indicator of obesity. Asia Pac J Clin Nutr. 2002; 11:Suppl 8. S681–S684.
Article
7. Lee AJ, Fowkes FG, Carson MN, Leng GC, Allan PL. Smoking, atherosclerosis and risk of abdominal aortic aneurysm. Eur Heart J. 1997; 18:671–676.
Article
8. Wong DR, Willett WC, Rimm EB. Smoking, hypertension, alcohol consumption, and risk of abdominal aortic aneurysm in men. Am J Epidemiol. 2007; 165:838–845.
Article
9. Jahangir E, Lipworth L, Edwards TL, Kabagambe EK, Mumma MT, Mensah GA, et al. Smoking, sex, risk factors and abdominal aortic aneurysms: a prospective study of 18 782 persons aged above 65 years in the Southern Community Cohort Study. J Epidemiol Community Health. 2015; 69:481–488.
Article
10. Wilmink TB, Quick CR, Day NE. The association between cigarette smoking and abdominal aortic aneurysms. J Vasc Surg. 1999; 30:1099–1105.
Article
11. Guzik B, Sagan A, Ludew D, Mrowiecki W, Chwała M, Bujak-Gizycka B, et al. Mechanisms of oxidative stress in human aortic aneurysms--association with clinical risk factors for atherosclerosis and disease severity. Int J Cardiol. 2013; 168:2389–2396.
Article
12. Siasos G, Mourouzis K, Oikonomou E, Tsalamandris S, Tsigkou V, Vlasis K, et al. The role of endothelial dysfunction in aortic aneurysms. Curr Pharm Des. 2015; 21:4016–4034.
Article
13. Pujades-Rodriguez M, George J, Shah AD, Rapsomaniki E, Denaxas S, West R, et al. Heterogeneous associations between smoking and a wide range of initial presentations of cardiovascular disease in 1937360 people in England: lifetime risks and implications for risk prediction. Int J Epidemiol. 2015; 44:129–141.
Article
14. Collins JA, Munoz JV, Patel TR, Loukas M, Tubbs RS. The anatomy of the aging aorta. Clin Anat. 2014; 27:463–466.
Article
15. De Rango P, Farchioni L, Fiorucci B, Lenti M. Diabetes and abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2014; 47:243–261.
Article
16. Celik T, Iyisoy A, Celik M, Tan Y. Dyslipidemia and abdominal aortic aneurysm: another piece of the puzzle? Int J Cardiol. 2010; 139:202–203.
Article
17. Wilmink AB, Vardulaki KA, Hubbard CS, Day NE, Ashton HA, Scott AP, et al. Are antihypertensive drugs associated with abdominal aortic aneurysms? J Vasc Surg. 2002; 36:751–757.
Article
18. Chun AS, Elefteriades JA, Mukherjee SK. Do betablockers really work for prevention of aortic aneurysms?: time for reassessment. Aorta (Stamford). 2013; 1:45–51.
20. Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006; 113:2363–2372.
Article
21. Hannawa KK, Eliason JL, Upchurch GR Jr. Gender differences in abdominal aortic aneurysms. Vascular. 2009; 17:Suppl 1. S30–S39.
Article
22. Ailawadi G, Eliason JL, Roelofs KJ, Sinha I, Hannawa KK, Kaldjian EP, et al. Gender differences in experimental aortic aneurysm formation. Arterioscler Thromb Vasc Biol. 2004; 24:2116–2122.
Article
23. Lee JK, Borhani M, Ennis TL, Upchurch GR Jr, Thompson RW. Experimental abdominal aortic aneurysms in mice lacking expression of inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol. 2001; 21:1393–1401.
Article
24. Manning MW, Cassi LA, Huang J, Szilvassy SJ, Daugherty A. Abdominal aortic aneurysms: fresh insights from a novel animal model of the disease. Vasc Med. 2002; 7:45–54.
Article
25. Fortmann SP, Ford E, Criqui MH, Folsom AR, Harris TB, Hong Y, et al. CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: report from the population science discussion group. Circulation. 2004; 110:e554–e559.
Article
26. Fakhrzadeh H, Ghotbi S, Pourebrahim R, Nouri M, Heshmat R, Bandarian F, et al. Total plasma homocysteine, folate, and vitamin B12 status in healthy Iranian adults: the Tehran homocysteine survey (2003–2004)/a cross-sectional population based study. BMC Public Health. 2006; 6:29.
Article
27. Schillinger M, Domanovits H, Ignatescu M, Exner M, Bayegan K, Sedivy R, et al. Lipoprotein (a) in patients with aortic aneurysmal disease. J Vasc Surg. 2002; 36:25–30.
Article
28. Hackam DG, Anand SS. Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA. 2003; 290:932–940.
Article